Ticker League

Cash on Hand for Boston Scientific (BSX) 1991-2026

As of · Reported

Metric

Latest period

$1.52B

YoY change

+394.0%

5Y CAGR

+3.4%

Peak year (FY2025)

$2.05B

Cash on Hand history chart for Boston Scientific (BSX) from 2016 to 2025

Latest: $2.05B

Cash on Hand growth chart for Boston Scientific (BSX) from 2016 to 2025

Latest: +394.0%

Cash on Hand history table for Boston Scientific (BSX) from 1991 to 2025

  • FY2025$2.05B+394.0%
  • FY2024$414M-52.1%
  • FY2023$865M-6.8%
  • FY2022$928M-51.8%
  • FY2021$1.93B+11.0%
  • FY2020$1.73B+699.1%
  • FY2019$217M+48.6%
  • FY2018$146M-22.3%
  • FY2017$188M-4.1%
  • FY2016$196M-38.6%
  • FY2015$319M-45.7%
  • FY2014$587M+170.5%
  • FY2013$217M+4.8%
  • FY2012$207M-22.5%
  • FY2011$267M+25.4%
  • FY2010$213M-75.3%
  • FY2009$864M-47.3%
  • FY2008$1.64B+13.0%
  • FY2007$1.45B-12.9%
  • FY2006$1.67B+96.7%
  • FY2005$848M-48.3%
  • FY2004$1.64B+144.4%
  • FY2003$671M+142.2%
  • FY2002$277M+49.7%
  • FY2001$185M+208.3%
  • FY2000$60M-23.1%
  • FY1999$78M+11.0%
  • FY1998$70.3M+21.2%
  • FY1997$58M-0.9%
  • FY1996$58.5M-49.1%
  • FY1995$115M+27.6%
  • FY1994$90.1M+48.2%
  • FY1993$60.8M-36.3%
  • FY1992$95.4M+1516.9%
  • FY1991$5.9M—

Cash on Hand values are taken from Boston Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Cash on Hand at Boston Scientific (BSX)

According to Boston Scientific's latest reported financial statements, the company's latest reported cash and short-term investments is $1.52B. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Boston Scientific (BSX) reported cash and short-term investments of $2.05B – surged 394.0% year-over-year.

Over 2020–2025 (5 years), Boston Scientific cash and short-term investments expanded at a +3.4% compound annual rate, with mixed annual results across the window.

Across the available history, cash and short-term investments reached its high of $2.05B in 2025 and its low of $5.9M in 1991.

Boston Scientific Cash on Hand by Year

Boston Scientific Cash on Hand 2025: $2.05B

Boston Scientific cash and short-term investments in 2025 was $2.05B, surged 394.0% from 2024. This figure represents the highest annual value in the available history.

Boston Scientific Cash on Hand 2024: $414M

2024's cash and short-term investments for Boston Scientific came in at $414M, plunged 52.1% below 2023.

Boston Scientific Cash on Hand 2023: $865M

Boston Scientific posted cash and short-term investments of $865M in 2023, declined 6.8% below 2022.

Boston Scientific Cash on Hand 2022: $928M

In 2022, Boston Scientific reported cash and short-term investments of $928M, plunged 51.8% below 2021.

Boston Scientific Cash on Hand 2021: $1.93B

Boston Scientific cash and short-term investments in 2021 was $1.93B.

See more financial history for Boston Scientific (BSX).

Sector peers by Cash on Hand

Healthcare peers of Boston Scientific (BSX), ranked by their latest cash and short-term investments

Frequently asked questions

Trains Cash & Reserves

Boston Scientific (BSX) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.